NCT05298787View on ClinicalTrials.gov

A Phase 1 SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

August 16, 2021

Study Completion Date

August 16, 2021

Conditions
Healthy Volunteer
Interventions
DRUG

RLS-0071

RLS-0071 is administered as an IV infusion

DRUG

Saline Placebo

Placebo is administered as an IV infusion

Trial Locations (1)

H3P 3P1

Altasciences, Montreal

All Listed Sponsors
lead

ReAlta Life Sciences, Inc.

INDUSTRY

NCT05298787 - A Phase 1 SAD/MAD Study of RLS-0071 in Healthy Volunteers in Support of a COVID-19 Development Program | Biotech Hunter | Biotech Hunter